Max Turner

Macro Trader
Currencies • Bonds • Risk Assets
Focused on global liquidity trends
Patience pays.

[Max Turner @MaxTurnerMarket]

$NTGR is already moving in the right direction.

Since today’s recommendation, the stock has risen by +1.74% from the opening price to the current mid-session level, trading at $24.15.

This isn’t about chasing hype—it’s about identifying quality investment opportunities before the masses catch on.

I focus on:
✅ Undervalued growth stocks
✅ Technical breakout opportunities
✅ Strong fundamental catalysts
✅ Investment opportunities with an excellent risk-reward ratio and asymmetric upside potential
$NTGR is a perfect example of “better safe than sorry.”
If you want to get a head start on these opportunities before they become hot trends, follow me. Every trading day, I share stock investment ideas, technical analysis, and market insights.
The next breakout could be even more spectacular. 🚀
#StockMarket #Nasdaq #Investing #GrowthStocks #AIStocks #Trading #WallStreet

[Max Turner @MaxTurnerMarket]

$SNES +17% Many members in the group have already followed my latest trading guidance and earned substantial returns! Missed this golden opportunity? Don't worry. Please click my WhatsApp link or add my WhatsApp number from my profile. Then reply to me, and I will invite you to join my group There, I will share carefully selected high-quality stock recommendations daily.
#CLRO #USStocks #Stock #StockMarket #StockTrading #SPY #QQQ #NVDA #Tesla #AIStocks

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$S ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$S ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

$AXTI +22% Many members in the group have already followed my latest trading guidance and earned substantial returns! Missed this golden opportunity? Don't worry. Please click my WhatsApp link or add my WhatsApp number from my profile. Then reply to me, and I will invite you to join my group There, I will share carefully selected high-quality stock recommendations daily.
#CLRO #USStocks #Stock #StockMarket #StockTrading #SPY #QQQ #NVDA #Tesla #AIStocks

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$A ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$A ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

$OUST: Focuses on digital LiDAR sensors, stereo vision cameras, and perception software platforms. Through its 2022 merger with Velodyne and the early 2026 acquisition of Stereolabs (a vision company), it has transformed from a pure hardware supplier into an “end-to-end sensing and perception platform,” serving vertical markets such as industrial automation, robotics, smart infrastructure, automotive, and defense. Its core mission is to provide cost-effective, scalable 3D perception solutions for autonomous driving, robotics, and smart cities, with the goal of becoming the foundational infrastructure for physical AI.

Q1 2026: Revenue of approximately $49 million (up 49% year-over-year), with product revenue growing for the 13th consecutive quarter; GAAP gross margin of 43%; adjusted EBITDA loss of approximately $7 million (narrowing); shipments >12,600 units; Cash and short-term investments of approximately $175 million; no debt.
Full-Year 2025: Revenue of approximately $169 million (+52%); TTM revenue of approximately $185 million.
Guidance: Q2 2026 revenue of $49.5 million to $52.5 million; full-year 2026 revenue guidance has been adjusted due to the unwinding of one-time royalty payments, but organic growth remains strong. Analyst consensus target price is approximately $52 (Strong Buy), with a high of $75.
Business validation: Over 700 BlueCity contract deployments; port automation expansion with major European customers; DoD-related heavy equipment projects; early customer traction for Rev8.

Ouster’s primary direct competitors are LiDAR manufacturers: Hesai (scale and cost advantages, particularly in the Chinese market), Luminar (focused on long-range automotive applications, with recent consolidation), Innoviz, Aeva, RoboSense, and others. Ouster stands out in terms of breadth across multiple verticals (industrial/robotics/infrastructure) and cost advantages in digital architecture; following the merger with Velodyne, its IP and product portfolio have become more comprehensive; Chinese manufacturers have a stronger advantage in automotive mass production scale, but Ouster benefits from its ties to BABA and Western supply chain security.
Comparison with SAP’s supply chain business: The two are not really in the same league. SAP is an enterprise software giant that provides software for supply chain management (SCM), ERP, integrated business planning (IBP), and more. It focuses on data-driven optimization of planning, inventory, and logistics, serving the digital transformation of large enterprises, with high switching costs and recurring cloud revenue. Ouster combines physical-layer hardware with perception software, providing real-world 3D data inputs (LiDAR/cameras) that can be integrated into upper-layer software systems like SAP (e.g., feeding sensor data into supply chain platforms for smart logistics and port automation). Ouster does not directly compete with SAP but rather complements it: physical AI sensing can enhance supply chain visibility and automation efficiency. SAP is more mature and profitable, with a completely different valuation logic; Ouster is a high-growth, unprofitable pure-play hardware sensing company.

Target Price: $39–$45
#Microsoft #Micron #SanDisk #NVIDIA #Amazon #SKHynix #Intel

[Max Turner @MaxTurnerMarket]

Semiconductor shares staged a powerful recovery on Thursday. Micron rose around 18%, Sandisk gained about 26%, and AMD advanced roughly 13%, lifting the PHLX Semiconductor Index by more than 8%. The rebound reflected growing confidence that AI demand remains strong following positive results from Microsoft and Amazon. Memory and AI-related names led the charge as investors rotated back into the sector after recent volatility.

#Microsoft #Azure #Semiconductors #SP500 #Nasdaq #AISpending #MarketCap

[Max Turner @MaxTurnerMarket]

Today’s standouts include $IREN climbing around 27%, $FCEL advancing nearly 30%, and $NBIS gaining about 28%. $IREN rides Bitcoin mining and AI data-center energy demand, $FCEL benefits from clean energy and fuel-cell contracts, while $NBIS reflects renewed interest in AI infrastructure plays. Momentum is strong but sentiment-driven — continuous monitoring recommended.
#ChipStocks #NVDA #MSFT #OilPrices #META #FedDecision #AAPL

[Max Turner @MaxTurnerMarket]

$STKH +32% Many members in the group have already followed my latest trading guidance and earned substantial returns! Missed this golden opportunity? Don't worry. Please click my WhatsApp link or add my WhatsApp number from my profile. Then reply to me, and I will invite you to join my group There, I will share carefully selected high-quality stock recommendations daily.
#CLRO #USStocks #Stock #StockMarket #StockTrading #SPY #QQQ #NVDA #Tesla #AIStocks

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$S ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$S ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

$NNNN: A small medical technology company focused on in vitro diagnostics (IVD), positioning itself as a provider of “decentralized, rapidly accessible diagnostic solutions.” Rather than operating as a traditional large-scale diagnostics giant, the company leverages multi-platform technologies (LFIA, FIA, CLIA, PCR, LAMP, dry chemistry, etc.) to cover point-of-care testing (POCT), over-the-counter (OTC) at-home testing, and laboratory settings, with the goal of making complex testing simpler, faster, and more accessible to the general public. Its core value lies in diversifying from pandemic-related products to multi-disease and veterinary diagnostics, pursuing sustainable growth with high gross margins.

The product portfolio spans multiple core platforms: Lateral Flow Immunoassay (LFIA) and Fluorescent Immunoassay (FIA)—suitable for rapid antigen/antibody testing.
Chemiluminescent Immunoassay (CLIA, including dry-chemistry versions)—enhancing sensitivity and point-of-care applicability.
Real-time PCR and LAMP (Loop-Mediated Isothermal Amplification)— — molecular diagnostics, with some systems capable of delivering results in approximately 15 minutes.
Dry chemistry platform—rapid determination of biochemical parameters from small sample volumes.
Application areas include infectious diseases, cardiovascular conditions, inflammation, tumor markers, endocrinology, drug abuse, and veterinary diagnostics. The advantages lie in portability, rapid turnaround, and cost control, making these solutions suitable for settings with limited resources or where immediate results are required.

Revenue is primarily driven by product sales (reagents + instruments) and platform expansion: Rather than relying on the sale of standalone, high-priced equipment, the business model is built on repeat purchases of high-margin reagents and consumables.
Transitioning from COVID-related products to a non-COVID portfolio (by 2025, non-COVID revenue accounted for approximately 80% of commercial IVD revenue).
Expanding into veterinary diagnostics, new dry chemistry product lines, and multi-disease test kits to increase average transaction value and customer loyalty.
In the long term, coverage may be expanded through regional distribution, laboratory partnerships, and new platform licensing.
The business model is asset-light with high gross margins (recent gross margin of approximately 87%), relying on product portfolio optimization rather than large-scale capital expenditures.

NNNN is a highly volatile small-cap stock that has recently been significantly driven by market risk appetite and stock-specific news. Unless there is a major sell-off in the broader market, monitor whether the stock can hold recent support levels and test higher resistance levels; during pullbacks, watch for trading volume and fundamental news (new product launches, orders, or partnerships).

#FedDecision #ChipStocks #NVDA #MU #OilPrices #MSFT #META

[Max Turner @MaxTurnerMarket]

The Federal Reserve held interest rates steady for a seventh consecutive meeting, yet a hawkish tone from Chair Kevin Warsh and three dissents favoring a hike pushed the 30-year Treasury yield to a 19-year high near 5.23%, intensifying inflation and policy concerns.
#RateHoldDecision #HawkishFed #LongBondYields #TreasurySelloff #InflationWorries #PolicyDissent

[Max Turner @MaxTurnerMarket]

Notable gainers: $ZBRA up around 7.5%, $HCA advancing nearly 7.4%, and $TER jumping higher on strong earnings. $ZBRA rides automation and logistics tech demand, $HCA benefits from robust healthcare utilization, while $TER shows strength in semiconductor testing equipment. Solid volume and relative strength stand out.
#NVDA #MU #SNDK #AMD #MSFT #META #AAPL

[Max Turner @MaxTurnerMarket]

$BLKB +19% Many members in the group have already followed my latest trading guidance and earned substantial returns! Missed this golden opportunity? Don't worry. Please click my WhatsApp link or add my WhatsApp number from my profile. Then reply to me, and I will invite you to join my group There, I will share carefully selected high-quality stock recommendations daily.
#CLRO #USStocks #Stock #StockMarket #StockTrading #SPY #QQQ #NVDA #Tesla #AIStocks

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$B ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

I won’t disclose the full stock ticker here:
$B ***. Intraday volatility is expected to range from 10% to 40%. In the group, I’ll provide: ? Entry reference range ? Clear stop-loss levels ? Real-time sell alerts . The reason is simple—once too many people know about it, the first-mover advantage is lost. If you want to know the stock market’s direction in advance, or if you’re a new follower, please click the WhatsApp number on my profile page to add me as a contact. I’ll then send you the stock information privately.
#StockMarket #StockTrading #NVDA #TSLA #AMD #SPY #QQQ

[Max Turner @MaxTurnerMarket]

$CTKB:
Makroökonomischer Kontext – Positive Rahmenbedingungen
Der Markt für Life-Science-Instrumente und Durchflusszytometrie profitiert vom langfristigen Wachstum der Nachfrage in den Bereichen Immunologie, Onkologie, Zelltherapie und Präzisionsmedizin. Die Nachfrage nach hochparametrischer Zellanalyse steigt in der Wirkstoffforschung und in klinischen Studien. Trotz zyklischer Belastungen bei der akademischen und staatlichen Finanzierung (z. B. durch die NIH) ist die Nachfrage in der biopharmazeutischen Industrie und im asiatisch-pazifischen Raum relativ stabil. Das weltweite Streben nach hochdimensionalen Daten und Kosteneffizienz begünstigt die Verbreitung der spektralen Durchflusszytometrie.
Um den 5. August 2026: Veröffentlichung des Q2-Ergebnisses 2026 und Aktualisierung der Gesamtjahresprognose – Bestätigung der Umsatzentwicklung (Gesamtjahresprognose 205–212 Mio. $, ein Anstieg von 2–5 % gegenüber dem Vorjahr), des Wachstums des wiederkehrenden Umsatzes sowie der Verbesserung der Bruttomarge und des bereinigten EBITDA; dies wirkt sich unmittelbar auf die kurzfristige Marktstimmung und die Neubewertung der Aktien aus.
Q3 2026: Abschluss der organisatorischen Umstrukturierung (drei Hauptgeschäftsbereiche: Lösungen und Klinik, Forschungstechnologie, Dienstleistungen), was voraussichtlich die Umsetzungseffizienz und die Marktdurchdringung steigern wird.
Vorantreiben der Kommerzialisierung neuer Produkte: Das Borealis-7-Lasersystem (einschließlich tiefem Ultraviolett/Infrarot, unterstützt über 60 Farbpanels, nach dem Early-Access-Programm noch breitere Verfügbarkeit) sowie die Erweiterung der Aurora-Evo-Automatisierung treiben den Absatz von Geräten und Reagenzien an.
Ausweitung der klinischen Anwendungen: Northern Lights-CLC und andere Produkte sind in der EU und in China bereits registriert bzw. zugelassen; das Zulassungsverfahren in den USA schreitet voran; Reagenzien und Dienstleistungen wachsen mit der installierten Basis (Ziel: anhaltendes zweistelliges Wachstum).

Pipeline-Übersicht – Kurzbeschreibung der Vermögenswerte
Kernstück ist die Full Spectrum Profiling (FSP)-Plattform für die spektrale Durchflusszytometrie: Geräte: Cytek Aurora / Aurora Evo (Analyse mit hoher Parameteranzahl), Northern Lights (preisgünstig/klinisch ausgerichtet), Aurora CS (Sortierung), Borealis (neues 7-Laser-System, unterstützt eine höhere Parameteranzahl und zukünftige Bildgebung), Muse Micro / Guava-Serie (Einstiegsmodelle), Amnis-Bildgebungs-Durchflusszytometer usw.
Reagenzien: Proprietäre Farbstoffe wie cFluor, die Panels mit hoher Farbtiefe unterstützen und das wiederkehrende Umsatzwachstum ankurbeln.
Software/Dienstleistungen: Cytek Cloud (über 26.000 Nutzer), Serviceverträge.
Fokus auf die klinische Umsetzung von Forschungsergebnissen (Immunologie, Onkologie, Infektionskrankheiten usw.), wobei die installierte Basis das Wachstum bei Reagenzien und Dienstleistungen vorantreibt.

Kursziel: 5,69 US-Dollar

#AAPL
#ChipStocks
#NVDA
#FOMC
#BigTechEarnings
#MU
#Semiconductors

[Max Turner @MaxTurnerMarket]

S&P 500 and Nasdaq futures edged higher on Wednesday morning as investors awaited the Federal Reserve’s interest-rate decision later in the day, while semiconductor shares remained volatile ahead of major Big Tech earnings reports.
#FedDecision #ChipStocks #BigTechEarnings #Nasdaq #SP500

[Max Turner @MaxTurnerMarket]

Opportunity is showing up clearly today. $PMN is advancing more than 26% on neuroscience pipeline progress, $TRIB gaining nearly 28% with biotech diagnostic strength, and $FIRY rising over 22% on elevated trading activity. Stay focused and capture the strength when it appears.
#PMN #TRIB #FIRY #TradingMotivation #StockMarket #Gainers #InvestSmart